Chandrakala Gutika in the Management of Prameha (Diabetes Mellitus Type 2): A Classical Drug Review with Evidence-Based Analysis of Active Principles

Abstract

Chandrakala Gutika is a traditional Ayurvedic polyherbomineral formulation (Kharaliya Rasayana) highly regarded in classical texts like Bhaishajya Ratnavali for treating Madhumeha (Type 2 Diabetes Mellitus). This chronic metabolic disease is particularly prevalent in South Asian populations. The formulation consists of eleven key ingredients- four minerals and seven herbs- processed by levigating them with Guduchi and Shalmali Kwatha before rolling them into pills (Gutika). A comprehensive review of classical literature like the Charaka Samhita and the Ayurvedic Pharmacopoeia of India, alongside modern pharmacological databases like PubMed, reveals that Chandrakala Gutika works through multi-targeted cellular and molecular pathways. Its energetic profile (Rasa Panchaka) is predominantly characterized by Sheeta Veerya (cooling potency, 55%), Laghu Guna (light attribute, 40%), and Katu Rasa (pungent taste, 35%). At a systemic level, the formulation breaks down disease pathogenesis (Samprapti Vighatana) and clears metabolic channels (Srotoshodhana). Modern scientific evidence shows its active components achieve this through multiple mechanisms: inhibiting alpha-glucosidase, sensitizing insulin via PPARγ and AMPK activation, protecting pancreatic beta-cells, and restoring vital antioxidant enzyme activities. Key active principles driving these effects include berberine from Guduchi, fulvic acid from Shilajitu, emblicanin-A/B and gallic acid from Amalaki, and nano-particulate tin oxide from Vanga Bhasma. Together, these ingredients work synergistically to address diabetes at molecular and cellular levels. However, validating these promising mechanisms requires future rigorous, randomized controlled clinical trials using fully standardized formulations.